Mem Sloan Kettering Cancer Center — New York, New York

Mem Sloan Kettering Cancer Center is a clinical research site located in New York, New York, United States.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Mem Sloan Kettering Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Advanced Renal Cell Carcinoma.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mem Sloan Kettering Cancer Center?

Mem Sloan Kettering Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mem Sloan Kettering Cancer Center conducted?

Mem Sloan Kettering Cancer Center has 1 clinical trials on record. Their work covers Advanced Renal Cell Carcinoma.

Is Mem Sloan Kettering Cancer Center accredited by Crixeo Health?

Mem Sloan Kettering Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mem Sloan Kettering Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.